首页
探索
nav.journalClub
趋势
更多
synapse
⌘+K
语言
简体中文
简体中文
Efficient use of open label extension data to support additional evidence of efficacy and disease modification hypotheses | Synapse
March 3, 2026
Efficient use of open label extension data to support additional evidence of efficacy and disease modification hypotheses
KH
Kent Hendrix
SH
Suzanne Hendrix
TetraLogic Pharmaceuticals (United States)
SD
Samuel P. Dickson
TetraLogic Pharmaceuticals (United States)
Key Points
Efficacy was further supported through careful analysis of open label extension data, enhancing treatment insights.
Key evidence identified from data analysis indicated significant outcomes related to disease modification over time.
The methodology involved utilizing open label extension data to explore hypotheses regarding efficacy and disease progression.
These findings may enable better therapeutic strategies, though confirmatory studies are warranted to substantiate evidence.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Hendrix et al. (Mon,) studied this question.
synapsesocial.com/papers/69a75edac6e9836116a29d2f
https://doi.org/https://doi.org/10.1016/j.jns.2025.124099
Mark Helpful
Like
Save
Bookmark
Relay
Share